格拉尼奥和:其抗癌功能的近期发展为补充性癌症治疗开辟了新的视野
Gauri Srivastava1, Esha Mukherjee1, Ruchika Mittal1
1Amity Institute of Biotechnology, 77282 Amity University , Sector-125, Noida 201303, Uttar Pradesh, India.
Zeitschrift fur Naturforschung. C, Journal of biosciences
|April 18, 2024
概括
植物化合物格拉尼奥尔和醇显示出作为癌症治疗的前景. 这些天然单烯可能会提高化疗的疗效,并为各种癌症提供新的治疗选择.
科学领域:
- 在瘤学瘤学.
- 自然产品化学 自然产品化学
- 分子生物学分子生物学
背景情况:
- 癌症是全球主要的死亡原因,每年有数百万人被诊断出癌症.
- 目前的癌症治疗有局限性,生存率仍然低于最佳水平.
- 来自植物的单烯,格兰和,已经显示出显著的抗癌潜力.
研究的目的:
- 为了审查格拉尼奥尔和的抗癌作用.
- 探索它们作为补充或替代癌症疗法的潜力.
- 为了阐明它们的分子作用机制.
主要方法:
- 系统审查过去5年发表的科学文献.
- 在体外和体内的研究分析关于geraniol和citral.
- 检查这些单烯调节的分子通路.
主要成果:
- 格拉尼奥尔和醇对广泛的癌症类型具有有效性,包括乳腺癌,肝癌和前列腺癌.
- 这些单烯可以通过向瘤信号通路来提高化疗的有效性.
- 研究已经阐明了它们抗癌活动背后的分子机制.
结论:
- 格拉尼奥尔和醇是癌症治疗的有前途的天然化合物.
- 它们可以作为有价值的辅助剂或替代治疗方法,以改善患者的治疗结果.
- 对其治疗应用的进一步研究是有必要的.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Electron Transport Chain: Complex I and II
13.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.1K


